LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity

Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. High-density lipoprotein sub-population profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24, 2181–2187, 2004.10.1161/01.ATV.0000146325.93749.a8Open DOISearch in Google Scholar

Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis. Joint Bone Spine 78, 179–183, 2011.10.1016/j.jbspin.2010.07.01620851020Open DOISearch in Google Scholar

Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10, 167–175, 1990.226185310.1016/0168-8227(90)90040-ZSearch in Google Scholar

Feingold KR, Grunfeld C. Introduction to Lipids and Lipoproteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000, 2018.Search in Google Scholar

Fellows K, Uher T, Browne RW, Weinstock-Guttman B, Horakova D, Posova H, Vaneckova M, Seidl Z, Krasensky J, Tyblova M, Havrdova E, Zivadinov R, Ramanathan M. Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients. J Lipid Res 56, 2010–2018, 2015.2624348410.1194/jlr.M060970458309026243484Search in Google Scholar

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52, 453–462, 2003.10.2337/diabetes.52.2.4531254062112540621Open DOISearch in Google Scholar

Giubilei F, Antonini G, Di Legge S, Sormani MP, Pantano P, Antonini R, Sepe-Monti M, Caramia F, Pozzilli C. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 106, 109–112, 2002.10.1034/j.1600-0404.2002.01334.x12100371Search in Google Scholar

Guerrero-Garcia JJ, Carrera-Quintanar L, Lopez-Roa RI, Marquez-Aguirre AL, Rojas-Mayorquin AE, Ortuno-Sahagun D. Multiple Sclerosis and Obesity: Possible Roles of Adipokines. Mediators Inflamm 2016: Article ID: 4036232, 2016.10.1155/2016/4036232Search in Google Scholar

Haffner SM, American Diabetes Association. Management of Dyslipidemia in Adults With Diabetes. Diabetes Care 26, s83–s86, 2003.10.2337/diacare.26.2007.S83Search in Google Scholar

Ito K, Yoshida H, Yanai H, Kurosawa H, Sato R, Manita D, Hirowatari Y, Tada N. Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol. Int J Cardiol 168, 3853–3858, 2013.10.1016/j.ijcard.2013.06.02323850319Search in Google Scholar

Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben JP, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJ. Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. Sci Rep 7, 43410, 2017.2823020110.1038/srep43410532249728230201Search in Google Scholar

Jorissen W, Vanmierlo T, Wens I, Somers V, Van Wijmeersch B, Bogie JF, Remaley AT, Eijnde BO, Hendriks JJA. Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients. Int J Mol Sci 19, E193, 2018.10.3390/ijms19010193579614229316715Open DOISearch in Google Scholar

Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, Blaha MJ, Kulkarni KR, Correa A, D’Agostino RB Sr, Jones SR, Toth PP; Lipoprotein Investigators Collaborative (LIC) Study Group. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Off-spring Cohort Studies. J Am Heart Assoc 5, e002765, 2016.10.1161/JAHA.115.002765Search in Google Scholar

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome; definitions and controversies. BMC Med 9, 48, 2011.10.1186/1741-7015-9-48Search in Google Scholar

Krauss RM, PaulT.Williams PT, Brensike J, Detre KM, Lindgren FT, Kelsey SF, Vranizan K, Levy RI. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. The Lancet 330, 62–66, 1987.10.1016/S0140-6736(87)92734-6Search in Google Scholar

Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27, 1496–1504, 2004.10.2337/diacare.27.6.149615161808Open DOISearch in Google Scholar

Lee JE, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S. Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism. Int J Cardiol 225, 327–331, 2016.10.1016/j.ijcard.2016.10.01527756036Search in Google Scholar

Mandoj C, Renna R, Plantone D, Sperduti I, Cigliana G, Conti L, Koudriavtseva T. Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis. Neurosci Lett 606, 156–160, 2015.10.1016/j.neulet.2015.08.05426342534Search in Google Scholar

Martin SS, Faridi KF, Joshi PH, Blaha MJ, Kulkarni KR, Khokhar AA, Maddox TM, Havranek EP, Toth PP, Tang F, Spertus JA, Jones SR. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry. Clin Cardiol 38, 660–667, 2015.2645919110.1002/clc.22470471561726459191Search in Google Scholar

Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470, 1999.10.2337/diacare.22.9.14621048051010480510Open DOISearch in Google Scholar

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419, 1985.10.1007/BF0028088338998253899825Open DOISearch in Google Scholar

Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K, Watanabe K, Watanabe Y, Mishina H, Kugiyama K. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Atherosclerosis 218, 163–167, 2011.10.1016/j.atherosclerosis.2011.04.04021605862Search in Google Scholar

Penesova A, Vlcek M, Imrich R, Vernerova L, Marko A, Meskova M, Grunnerova L, Turcani P, Jezova D, Kollar B. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis. Metab Brain Dis 30, 895–901, 2015.10.1007/s11011-015-9665-12580913525809135Open DOISearch in Google Scholar

Sicras-Mainar A, Ruiz-Beato E, Navarro-Artieda R, Maurino J. Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain. BMC Neurol 17, 134, 2017.10.1186/s12883-017-0914-2551274828716070Open DOISearch in Google Scholar

Srisawasdi P, Vanavanan S, Rochanawutanon M, Kruthkul K, Kotani K, Kroll MH. Small-dense LDL/large-buoyant LDL ratio associates with the metabolic syndrome. Clin Biochem 48, 495–502, 2015.10.1016/j.clinbiochem.2015.01.01125645359Search in Google Scholar

Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75, 124–130, 1987.10.1161/01.CIR.75.1.124Search in Google Scholar

Tettey P, Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Dwyer T, Kostner K, van der Mei I. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler 20, 1737–1744, 2014.10.1177/135245851453316224829292Open DOISearch in Google Scholar

Torres A, Askari AD, Malemud CJ. Cardiovascular disease complications in systemic lupus erythematosus. Biomark Med 3, 239–252, 2009.10.2217/bmm.09.1420477476Open DOISearch in Google Scholar

Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13, 981–1000, 2014.10.1016/j.autrev.2014.07.00125092612Open DOISearch in Google Scholar

Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 8, 127, 2011.10.1186/1742-2094-8-127322878221970791Search in Google Scholar

Wens I, Dalgas U, Stenager E, Eijnde BO. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis – a systematic review. Mult Scler 19, 1556–1564, 2013.10.1177/135245851350425224048545Open DOISearch in Google Scholar